Modulation of Hepatitis B Virus (HBV) Expression
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 61/478,040, filed Apr 21, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,642,752 | Modulation of Hepatitis B Virus (HBV) Expression In force · High confidence UsedRemaining | Glaxo Group Limited | In force | High confidence | ||
| US 9,034,841 | Modulation of Hepatitis B Virus (HBV) Expression In force · High confidence | Glaxo Group Limited | In force | High confidence | ||
| US 9,127,278 | Modulation of Hepatitis B Virus (HBV) Expression In force · High confidence | Glaxo Group Limited | In force | High confidence | ||
| US 9,677,076 | Modulation of Hepatitis B Virus (HBV) Expression In force · High confidence | Glaxo Group Limited | In force | High confidence | ||
| Application 15/587,668 | Modulation of Hepatitis B Virus (HBV) Expression Abandoned Abandoned Aug 13, 2019 | Glaxo Group Limited | Abandoned | Abandoned Aug 13, 2019 | ||
| Application 16/522,490 | Modulation of Hepatitis B Virus (HBV) Expression Abandoned Abandoned Sep 8, 2021 | Glaxo Group Limited | Abandoned | Abandoned Sep 8, 2021 | ||
| Application 17/389,599 | Modulation of Hepatitis B Virus (HBV) Expression Pending Not granted | Glaxo Group Limited | Pending | Not granted |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Glaxo Group Limited.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.